Abstract 4370702: Proteomic Predictors of Incident Coronary Heart Disease in Individuals with CAC=0.
Abstract
Introduction: Coronary artery calcium (CAC) is an increasingly important clinical marker of coronary heart disease (CHD) and disease progression. However, a significant proportion of individuals suffer from CHD without antecedent CAC. There have been no studies describing a biochemical signature of individuals with CAC=0 that subsequently develop CHD. Research Question: Are there a specific set of proteins that are associated with incident CHD in low-risk individuals, as defined by undetectable CAC? Methods: In a prospective, case-cohort analysis, we measured 2,941 proteins (Olink) in 6,033 participants in the Multi-Ethnic Study of Atherosclerosis (MESA, mean age 56), among which 3,016 had CAC= 0. Cox proportional hazards regression models were used for incident CHD analyses with 20 years of follow-up. Age-, sex-, and batch-adjusted regression analyses were performed for each protein. We further adjusted for the following covariates: BMI, eGFR, diabetes mellitus, hypertension, total cholesterol, and smoking status. Participants with prevalent CHD and those without CAC scores were excluded. We used an FDR adjusted q-value < 0.05 to account for multiple hypothesis testing. Replication was performed in a low risk subset in the UKBB (n= 21,021, mean age 56, free of obesity, kidney dysfunction, HTN, DM, hypercholesterolemia, and smoking) Results: There were a total of 90 cases of incident CHD (defined as myocardial infarction (MI), resuscitated cardiac arrest due to MI, CHD death). In MESA participants with CAC=0, 140 proteins associated with CHD in the fully adjusted model, of which 53 replicated in the UKBB. Novel proteins included pro-neuropeptide Y (HR 1.54, q-value 0.02) a potent vasoconstrictor; GPR 37 (HR 1.87, q-value 0.0003), a shed surface receptor enriched on neurons, and shisa 5 (HR 1.49, p-value 0.04) a DNA damage-related protein previously linked to MI in GWAS studies. Conclusion: We present novel findings of protein associations with incident CHD in in individuals with undetectable CAC, with replication of a subset of findings in a second low-risk cohort. These findings could ultimately better risk stratify low-risk individuals for CHD and illuminate pathways orthogonal to established atherosclerotic disease mechanisms.
Article Details
Authors (11)
Daniel Cruz
Shuliang Deng
Cardiovascular Research Center (J.M.R., M.B., G.T., S.D., P.R., U.A.T., X.S., Y.G., F.-G.T., J.L.B., J.G.W., R.E.G.), Beth Israel Deaconess Medical Center, Boston, MA.t
Benson Mark
BIDMC, Brookline, Massachusetts, United States
Zsu-Zsu Chen
Beth Israel Lahey Health, Boston, Massachusetts, United States
Jeremy Robbins
Usman Tahir
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Jerome Rotter
The Lundquist Institute, Torrance, California, United States
Kent Taylor
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States
Matthew Budoff
The Lundquist Institute, Torrance, California, United States
Stephen Rich
Robert Gerszten